close close
Labtec Pharma Homepage
  • Extranet login|
  • Sitemap|
  • Search|
  • Contact|
  • www.tesa.com|

http://www.labtec-pharma.com/img/underscore_blue.gif http://www.labtec-pharma.com/img/underscore.gif
  • DRUG DELIVERY SYSTEMS|
    • Transdermal Systems (TDS)
    • Topical Patches
    • Buccal Patches
    • Oral Dissolvable Films (ODF)
  • PORTFOLIO|
  • SERVICES|
    • Contract Development
    • Contract Manufacturing
  • COMPANY|
    • Profile
    • History
    • Press Center
    • Jobs
    • How to find us
  • Contact
  • Imprint
  • Conditions of use / Privacy
  • Sitemap
 
  • Homepage > 
  • Meta > 
  • Sitemap

Sitemap


  • Drug Delivery Systems
  • Portfolio
  • Services
  • Company
DRUG DELIVERY SYSTEMSback to top back to top
  • Transdermal Systems (TDS)
  • Topical Patches
  • Buccal Patches
  • Oral Dissolvable Films (ODF)

PORTFOLIOback to top back to top

SERVICESback to top back to top
  • Contract Development
  • Contract Manufacturing

COMPANYback to top back to top
  • Profile
  • History
  • Press Center
  • Jobs
  • How to find us

back to top ^
Print view | Bookmark
close close
  • del.icio.us
  • Google Bookmarks
  • Mister Wong
  • Facebook
  • mySpace
  • Furl
  • Webnews
  • YiGG
DIRECT CONTACT
Fon: +49 (2173) 9735-0
Fax: +49 (2173) 9735-35
DIRECT CONTACT Contact us

PRESS CENTER

06/21/10
Labtec and GSK finalize license agreement for an innovative topical patch to treat cold sores

GlaxoSmithKline acquired the exclusive marketing rights for a new topical patch for the treatment of cold sores from Labtec. >>

03/23/10
European Approval of Ondansetron Rapidfilm®

APR Applied Pharma Research s.a. and Labtec GmbH announce the European Approval of Ondansetron Rapidfilm®, co-developed in partnership with MonoSol Rx and licensed to BioAlliance Pharma SA for EU countries. >>

10/06/09
“An important role in our business with the pharmaceutical industry”

Interview with Joachim Suesse, Head of the Business Unit tesa Health Markets >>

© Labtec GmbH - A tesa Company | Imprint and Privacy Policy|